Slovenia starts using monoclonal antibody treatment for Covid-19 patients
Slovenia has started using monoclonal antibody treatment for some patients with Covid-19, having received a shipment of 1,000 doses of a drug as part of an EU contract. The combination of two antibody treatments, casirivimab and imdevimab, is used at the request of attending physicians under a temporary permit from the Slovenian Agency for Medicinal …
Slovenia starts using monoclonal antibody treatment for Covid-19 patients Read More »